Literature DB >> 10146736

Epidemiology and screening of open-angle glaucoma.

R P Crick1.   

Abstract

Two major prevalence surveys for chronic open-angle glaucoma have been published in the last year. These are discussed in relation to the comprehensive Baltimore Eye Survey of 2 years ago, which also studied the blindness arising from the disease and comparative figures for white and black individuals. The newer tests for identification of loss of visual function prior to visual field loss as demonstrated by conventional automated perimetry are considered. The three main screening tests for chronic open-angle glaucoma--ophthalmoscopy, tonometry, and perimetry--are evaluated in the light of case finding experience in the United Kingdom. The maximum detection of asymptomatic early chronic open-angle glaucoma in the community is likely to be best achieved by a combination of public awareness of glaucoma aided by patient-based associations and the promotion of improved glaucoma testing and case finding by the army of professionals who are already in place in most developed countries and who carry out primary eye examinations.

Entities:  

Mesh:

Year:  1994        PMID: 10146736     DOI: 10.1097/00055735-199404000-00002

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  4 in total

1.  [Do we take care of glaucoma from primary care?].

Authors:  N Marañón Heinrich; J Jaén Díaz; I Sanz Alcolea; F López De Castro
Journal:  Aten Primaria       Date:  2001-03-31       Impact factor: 1.137

2.  Prevalence of primary open angle glaucoma in general ophthalmic practice in the United Kingdom.

Authors:  M Kroese; H Burton; S Vardy; T Rimmer; D McCarter
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

Review 3.  Primary open angle glaucoma. The need for a consensus case definition.

Authors:  M Kroese; H Burton
Journal:  J Epidemiol Community Health       Date:  2003-09       Impact factor: 3.710

4.  Assessing sexual functioning in patients with chronic disorders by using a generic health-related quality of life questionnaire.

Authors:  P E Wändell; B Brorsson
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.